Back to resources
Why it matters
Researchers from AstraNova's molecular pharmacology group and collaborating academic partners publish a validated platform for high-throughput PROTAC degradation kinetics and ternary complex assessment in Nature Chemical Biology.
Scientific context
Discovery programs increasingly require decision-grade data that connects target biology, modality strategy, translational relevance, and operational timing. AstraNova structures each platform update and scientific resource around that decision framework.
Partner impact
For biotech and pharmaceutical teams, the practical value is faster experimental alignment, clearer risk interpretation, and more confident movement between discovery milestones without sacrificing rigor.